Identification of mcr-8 in Clinical Isolates From Qatar and Evaluation of Their Antimicrobial Profiles
This study was performed to investigate the genotypic causes of colistin resistance in 18 colistin-resistant Klebsiella pneumoniae ( n = 13), Escherichia coli ( n = 3) and Pseudomonas aeruginosa ( n = 2) isolates from patients at the Hamad General Hospital, Qatar. MIC testing for colistin was perfor...
Saved in:
Published in: | Frontiers in microbiology Vol. 11; p. 1954 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Frontiers Media S.A
24-08-2020
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | This study was performed to investigate the genotypic causes of colistin resistance in 18 colistin-resistant
Klebsiella pneumoniae
(
n
= 13),
Escherichia coli
(
n
= 3) and
Pseudomonas aeruginosa
(
n
= 2) isolates from patients at the Hamad General Hospital, Qatar. MIC testing for colistin was performed using Phoenix (BD Biosciences, Heidelberg, Germany) and then verified with SensiTest Colistin (Liofilchem, Zona Ind. le, Italy). Strains determined to be resistant (MIC > 4-16 μg/mL) were then whole-genome sequenced (MiSeq, Illumina, Inc.). Sequences were processed and analysed using BacPipe v1.2.6, a bacterial whole genome sequencing analysis pipeline. Known chromosomal modifications were determined using CLC Genomics Workbench v.9.5.3 (CLCbio, Denmark). Two
K. pneumoniae
isolates (KPN-15 and KPN-19) harboured
mcr-8.1
on the IncFII(K) plasmids, pqKPN-15 and pqKPN-19, and belonged to ST383 and ST716, respectively. One
E. coli
isolate harboured
mcr-1.1
on the
IncI2
plasmid pEC-12. The other 15 isolates harboured known chromosomal mutations linked to colistin resistance in the PhoPQ two-component system. Also, three
K. pneumoniae
strains (KPN-9, KPN-10 and KPN-15) showed disruptions due to IS elements in
mgrB
. To our knowledge, this marks the first description of
mcr-8.1
in
K. pneumoniae
of human origin in Qatar. Currently, more research is necessary to trace the source of
mcr-8.1
and its variants in humans in this region. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Patrick Rik Butaye, Ross University School of Veterinary Medicine, Saint Kitts and Nevis Reviewed by: Youjun Feng, Zhejiang University, China; Chengming Wang, Auburn University, United States This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology |
ISSN: | 1664-302X 1664-302X |
DOI: | 10.3389/fmicb.2020.01954 |